TRIVASCULAR TECHNOLOGIES, INC. Up to $25,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementTriVascular Technologies, Inc. • May 29th, 2015 • Surgical & medical instruments & apparatus • New York
TriVascular Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
